Dendreon (DNDN) +6.9% - although down from earlier highs - on rumors it might be trying to sell...

This news story has 6 comments:

Register or Login to rate comments »

Gary Jakacky Comments (1832)
 
What a joke of a company. When ya can't sell your product, sell additional shares. When the saps gettired of bying additional shares, sell the whole firm!
24 Jul 2012, 11:31 AM Reply Like

Mike Maher Comments (1747)
 
Trying to sell the firm after shares fall 80% from the 52-week high seems like a poor strategy.
24 Jul 2012, 11:44 AM Reply Like

Adel.Nashville Comments (47)
 
This is "rumors "
Read what JJ said, this is his last company, that does not sound logical
24 Jul 2012, 11:54 AM Reply Like

barneyb1 Comments (2)
 
My oncologist started advocating Provenge for me even before it got approved. Then when it was appoved, we referred me to a specialist that did the Provenge thing but he informed me at that time that it was not accepted by Medicare. Later when it was accepted by Medicare, I went for an interview and found out that it was only being used on patients whose prostate cancer had metastized. Fortunately mine has not and I was turned down.
I bought stock in DnDn and made some good money it in non-approved and early approved days but I don't understand the management of this company and their inability to sell this product to the medical profession and to the public. Why wait until the patient is dead and give them the treatment? It appears to me that this company and Dr. Gold in particular has developed Provenge (their only product) for the sole reason to make Dr. Gold rich...and it has. Hasn't done ole barney b smith much good though.
24 Jul 2012, 01:46 PM Reply Like

Adel.Nashville Comments (47)
 
You do not build a huge company over night
If your oncologist started advocating Provenge for you even before it got approved, you should have more trust in it's potential now.
24 Jul 2012, 02:59 PM Reply Like

rockiemoon Comments (26)
 
Provenge is a good drug, but the previous sale team really sucks
24 Jul 2012, 05:35 PM Reply Like